Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDestiny Pharma. Share News (DEST)

Share Price Information for Destiny Pharma. (DEST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.25
Bid: 18.00
Ask: 18.50
Change: 0.00 (0.00%)
Spread: 0.50 (2.778%)
Open: 18.25
High: 18.25
Low: 18.25
Prev. Close: 18.25
DEST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Belluscura to raise GBP5 million; React buys

Thu, 12th May 2022 19:45

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Syncona Ltd - investor in healthcare companies - portfolio company, Autolus Therapeutics PLC to present data at European Hematology Association's Congress on June 9-12. Data includes positive early safety and efficacy data from AUTO4 in T cell lymphoma, and promising early data in AUTO1/22 programme in paediatric acute lymphoblastic leukaemia, as well as AUTO1 early safety and efficacy for relapsed/refractory primary central nervous system lymphoma.

----------

Faron Pharmaceuticals Ltd - Turku, Finland-based clinical stage biopharmaceutical company - Will present data on the potential of bexmarilimab in combination with standard of care for blood cancers at the European Hematology Association's Congress. Bexmarilimab is its wholly-owned novel precision cancer immunotherapy. It targets the Clever-1 receptor, which is associated with tumour-associated macrophages. "High Clever-1 expression is associated with poor survival in certain blood cancer patients and bexmarilimab provides a novel treatment approach for these patients, downregulating Clever-1 expression and igniting an effective immune response. We look forward to the imminent start of our hematology cancer clinical trial program to further explore these promising findings," says Chief Medical Officer Marie-Louise Fjallskog.

----------

Verici Dx PLC - Tennessee-based developer of clinical diagnostics for organ transplants - Results blinded, international, multi-centre validation study for Tuteva blood test showed significantly higher Positive Predictive Value for Tuteva than currently available kidney transplant blood tests. "The results reflect the wide clinical applicability of the test for comprehensive commercial adoption in a real-world setting," Verici says.

----------

Water Intelligence PLC - London-based leak detection services - Reacquires franchise in central Texas held within American Leak Detection subsidiary for USD750,000 cash, building upon acquisition of Forth Worth, Texas franchise in January. "The group is executing this regional hub model across the United States with its more than 150 corporate and franchise locations," the company says.

----------

Graft Polymer (UK) PLC - Slovenia-based polymer modification and drug delivery systems -Is granted Hazard Analysis & Critical Control Point certificate for its R&D facility in Slovenia for GraftBio division. "The HACCP certificate will allow us to create a strong reputation in the B2C market as a manufacturer of quality and safe food supplements, selling direct to consumers over time - a more lucrative revenue stream," says Chief Executive Officer Victor Bolduev.

----------

React Group PLC - South Derbyshire, England-based cleaning, hygiene and decontamination firm - Completes acquisition of window, gutter and cladding business LaddersFree Ltd for up to GBP8.5 million. GBP4.7 million is paid in cash, with GBP1.0 million in 83.3 million new ordinary shares at 1.2 pence each. Deferred consideration of GBP1.5 million to be paid in instalments. The acquired company has a "consistent track record of organic revenue growth and profitability", React says, and will broaden its customer base, reducing dependence on reactive and ad hoc work.

----------

AEX Gold Inc - Greenland-focused gold miner - Acquires mineral exploration licences No. 2020-41 and 2021-11 covering areas in south Greenland from Orano Group for no upfront consideration but a royalty on future production. The acquisition means AEX will be the largest licence holder in region, and the third-largest in Greenland, after Anglo American PLC and Greenfield Exploration. "We are excited to be substantially increasing our exposure to strategic metals and rare earth elements across Greenland. Greenland has the potential to become a crucial supplier of these vital minerals to the Western world, and AEX intends to be a key player in this," says Chief Executive Officer Eldur Olafsson.

----------

Puma VCT 12 PLC - venture capital trust managed by Puma Investments - Announces Sunlight Education Nucleus Ltd has been acquired, in which it invested GBP2.4 million in 2017. Exit represents 3.2 times return on its equity investment.

----------

Avation PLC - Singapore-based passenger aircraft leasing company - Completes second sale of series of ex-Virgin Australia Airlines ATR72-600s to Aegean Airlines for unspecified amount. Executive Chair Jeff Chatfield says: "Avation continues to reduce its few remaining unutilised aircraft in the fleet. We anticipate zero unutilised aircraft by the end of the calendar year 2022. Sales of unutilised aircraft provide capital to rebuild in a post-pandemic recovery phase."

----------

Belluscura PLC -London-based medical device developer - Will raise GBP5 million in accelerated bookbuild via placing of new shares. Proceeds will be used to fund the purchase of raw material inventory and non-recurring costs of manufacturing and engineering, in relation to its manufacturing agreement with InnoMax Medical Technology Ltd. Dowgate Capital Ltd is acting as sole placing agent, bookrunner and broker, with SPARK Advisory Partners Ltd acting as nominated adviser.

----------

Circle Property PLC - London-based buyer, developer and manager of regional office assets in UK - Has exchanged contracts for the sale of 720 Aztec West in Bristol to Maybrook Properties Ltd. Sale price of GBP2.5 million is a 77% increase on the valuation of GBP1.4 million at the end of March last year.

----------

Clontarf Energy PLC - Dublin-headquartered oil & gas exploration and production company focused on South America and Africa - Updates on drilling for Sasanof-1 exploration well. Says Valaris MS-1 rig is anchored in Dampier outer harbour, scheduled to commence tow to Sasanof-1 location on Monday. The operator Western Gas' drilling operations dteam are deployed to field and with now onboard MS-1 rig and undertake pre-mobilisation checks. Support vessels started operations on time on Monday. Drilling operations are expected to start on May 24. Has 10% working interest in Sasanof.

----------

Molten Ventures PLC - London-based venture capital firm focused on technology companies - Says portfolio company Aiven, a Finnish software company, closes externally-led series D funding round, raising USD210 million. Valuation of Aiven now USD3 billion, a "significant uplift on earlier rounds". Molten holds interest through Earlybird Partnership. Says carrying value of its holding in Aiven will be finalised as part of its final results on June 13.

----------

Mercia Asset Management PLC - regionally focused specialist asset manager – Says Knowledge-Intensive and annual Enterprise Investment Scheme funds raise total of around GBP20 million in new capital over past year.

----------

Kefi Gold & Copper PLC - Cyprus-based gold and copper exploration and development company with projects in Ethiopia and Saudi Arabia - Says progress in Ethiopia remains on track over past month, and multi-party project financing is developing. Expects to sign umbrella financing agreement this quarter, with full construction to commence from October, at the end of the current wet season. "KEFI has been able to pivot onto a much more positive direction since December 2021 due to geopolitics, regulatory changes and exploration results. We now have three advanced projects in two countries that are now overtly pro-development - a more positive and less risky position than KEFI has confronted for many years," says Executive Chair Harry Anagnostaras-Adams.

----------

European Metals Holdings Ltd - mineral exploration and development company focused on Cinovec lithium-tin project in Czech Republic - Accepted to trade on US based OTCQX Best Market, under the codes "EMHXY", "ERPNF" and "EMHLF" from Thursday. "Trading on the OTCQX comes at a pivotal time for investors seeking to leverage the transition away from fossil fuels, with the European Union offering significant funding to accelerate change and adoption rates of electric vehicles in the region continuing to climb," says Executive Chair Keith Coughlan.

----------

Future Metals NL - Perth-based platinum exploration company - Reports wide PGM assay results from drillhole samples at 100%-owned Panton PGM Project in northern Western Australia. Highlights include 60.5 metres at 1.24 grams per tonne palladium equivalent from 0 metres. "All drill hole results returned to date have confirmed significant intercepts of mineralisation, demonstrating the strong continuity of the Panton orebody along its current 3.5km strike, and the lateral extent of mineralisation sitting outside of the chromite reefs," says Chief Executive Officer & Managing Director Jardee Kininmonth. Is targeting new mineral resource estimate release in the coming weeks.

----------

Destiny Pharma PLC - Brighton-based clinical phase biotechnology company - Says data previously reported for c. difficile infection model study is accepted for presentation at Anaerobe 2022 Conference in Seattle. Data is on the ability of non-toxigenic strain M3 to colonise the gut following antibiotics. "The relevance and impact of this study cannot be underestimated as it indicates that the clinical use of fidaxomicin to treat CDI is unlikely to affect the ability of Destiny's late-stage asset, NTCD-M3, to colonise the gut and prevent recurrence of CDI," explains Chief Scientific Officer Bill Love.

----------

Mattioli Woods PLC - Leicester, England-based asset manager - Says subsidiary Ludlow Wealth Management Group Ltd has acquired Ferguson Financial Management Ltd for an initial GBP600,000 and potential further consideration of up to GBP600,000 million dependent on the attainment of performance targets in the year after completion.

----------

Capital Metals PLC - developing eastern minerals project in Sri Lanka - Says study for project demonstrates "exceptional economics" resulting in a high margin operation, enabling a short payback period. Says the long-term price assumptions used are below current prices suggesting "even more attractive economics are feasible". Further, it says the study does not take into account any potential resource extensions, which would enable the expansion of mine life and throughput, providing even further upside.

----------

HeiQ PLC - Zurich-based materials developer - Will pay deferred considerations relating to acquisitions of RAS AG and Life Material Technologies Ltd. Will pay EUR2.6 million to RAS based on its annual performance through ordinary shares of 30 pence each in HeiQ capital. Will pay USD2.8 million to Life, settled half in cash and half in new ordinary shares. Total new shares allotted for the transactions are 3.5 million.

----------

By Elizabeth Winter; elizabethwinter@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
25 Apr 2024 20:57

TRADING UPDATES: Norcros sells Johnson Tiles UK; Trifast trading well

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
25 Apr 2024 10:23

AIM WINNERS & LOSERS: Kromek jumps 14% on US government contract

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
18 Apr 2024 14:17

UK earnings, trading statements calendar - next 7 days

Friday 19 April 
888 Holdings PLCTrading Statement
Man Group PLCTrading Statement
Monday 22 April 
Brave Bison Group PLCFull Year Results
Elixirr International PLCFull Year Results
Frenkel Topping Group PLCFull Year Results
Mobico Group PLCFull Year Results
South32 LtdQ3 Results
Ten Lifestyle Group PLCHalf Year Results
Tuesday 23 April 
Alliance Pharma PLCFull Year Results
Alphawave IP Group PLCFull Year Results
Anglo American PLCTrading Statement
ASA International Group PLCFull Year Results
Associated British Foods PLCHalf Year Results
Eleco PLCFull Year Results
GB Group PLCTrading Statement
Jupiter Fund Management PLCTrading Statement
Maintel Holdings PLCFull Year Results
Property Franchise Group PLCFull Year Results
Taylor Wimpey PLCTrading Statement
tinyBuild IncFull Year Results
Trellus Health PLCFull Year Results
Wednesday 24 April 
1Spatial PLCFull Year Results
abrdn PLCTrading Statement
Ecora Resources PLCTrading Statement
Fresnillo PLCTrading Statement
Lloyds Banking Group PLCQ1 Results
Nichols PLCTrading Statement
PensionBee Group PLCFirst Quarter Results
PZ Cussons PLCTrading Statement
Reckitt Benckiser Group PLCTrading Statement
Sanderson Design Group PLCFull Year Results
Serica Energy PLCFull Year Results
Star Energy Group PLCFull Year Results
Tortilla Mexican Grill PLCFull Year Results
Tracsis PLCHalf Year Results
Warpaint London PLCFull Year Results
Thursday 25 April 
Aquila European Renewables PLCFull Year Results
Argo Blockchain PLCFull Year Results
AstraZeneca PLCQ1 Results
Barclays PLCQ1 Results
Checkit PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Destiny Pharma PLCFull Year Results
Hikma Pharmaceuticals PLCTrading Statement
Focusrite PLCHalf Year Results
Ibstock PLCTrading Statement
Inchcape PLCTrading Statement
J Sainsbury PLCFull Year Results
London Stock Exchange Group PLCQ1 Results
Persimmon PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
PureTech Health PLCFull Year Results
Relx PLCTrading Statement
Renewi PLCTrading Statement
Schroders PLCQ1 Results
Skillcast Group PLCFull Year Results
Travis Perkins PLCTrading Statement
Trifast PLCTrading Statement
Unilever PLCQ1 Results
WAG Payment Solutions PLCTrading Statement
Weir Group PLCTrading Statement
WH Smith PLCHalf Year Results
WPP PLCTrading Statement
Zinc Media Group PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
31 Jan 2024 18:28

EARNINGS AND TRADING: STV raises holding in Two Cities Television

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
4 Jan 2024 14:07

Destiny Pharma seeks to capitalise on XF-73 market potential in 2024

(Alliance News) - Destiny Pharma PLC on Thursday said that its priority remains promoting its XF-73 Nasal antibacterial drug.

Read more
4 Jan 2024 11:27

Destiny Pharma reports progress on clinical assets

(Sharecast News) - Clinical-stage biotechnology company Destiny Pharma said in a year-end update on Thursday that its primary focus remained on realising the full potential of its XF-73 Nasal asset.

Read more
29 Oct 2023 21:01

Sunday share tips: Destiny Pharma, Invinity Energy Systems

(Sharecast News) - The Financial Mail on Sunday's Midas column spied long-term potential in Destiny Pharma's shares.

Read more
17 Oct 2023 11:15

Destiny Pharma celebrates study findings on "potent" flagship drug

(Alliance News) - Destiny Pharma PLC shares soared on Tuesday after new data showed XF-73, its leading antibacterial drug, to be effective against over 2,500 Staphylococcus isolates, including resistant strains.

Read more
17 Oct 2023 10:18

AIM WINNERS & LOSERS: Destiny Pharma posts "landmark" XF-73 data

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more
20 Sep 2023 14:27

TRADING UPDATES: Dianomi swings to loss; Epwin revenue up

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
13 Sep 2023 15:48

UK earnings, trading statements calendar - next 7 days

Thursday 14 September 
Arecor Therapeutics PLCHalf Year Results
Brooks Macdonald Group PLCFull Year Results
Capricorn Energy PLCHalf Year Results
Checkit PLCHalf Year Results
Churchill China PLCHalf Year Results
Foresight Solar Fund LtdHalf Year Results
Glenveagh Properties PLCHalf Year Results
IG Group Holdings PLCTrading Statement
Keystone Law Group PLCHalf Year Results
Kier Group PLCFull Year Results
M&C Saatchi PLCHalf Year Results
MJ Gleeson PLCFull Year Results
Oakley Capital Investments LtdHalf Year Results
Renishaw PLCFull Year Results
Spire Healthcare Group PLCHalf Year Results
THG PLCHalf Year Results
Trainline PLCTrading Statement
Uniphar PLCHalf Year Results
Friday 15 September 
Petra Diamonds LtdFull Year Results
VH Global Sustainable Energy Opportunities PLCHalf Year Results
Monday 18 September 
Artisanal Spirits Co PLCHalf Year Results
City of London Investment Group PLCFull Year Results
Downing Renewables & Infrastructure Trust PLCHalf Year Results
Facilities by ADF PLCHalf Year Results
Futura Medical PLCHalf Year Results
Greencoat Renewables PLCHalf Year Results
HgCapital Trust PLCHalf Year Results
Phoenix Group Holdings PLCHalf Year Results
S4 Capital PLCHalf Year Results
Tuesday 19 September 
accesso Technology Group PLCHalf Year Results
Billington Holdings PLCHalf Year Results
Big Technologies PLCHalf Year Results
C&C Group PLCTrading Statement
Concurrent Technologies PLCHalf Year Results
CPPGroup PLCHalf Year Results
Eagle Eye Solutions Group PLCFull Year Results
Fintel PLCHalf Year Results
Good Energy Group PLCHalf Year Results
Hargreaves Lansdown PLCFull Year Results
Henry Boot PLCHalf Year Results
Kingfisher PLCHalf Year Results
Litigation Capital Management LtdFull Year Results
Maintel Holdings PLCHalf Year Results
McBride PLCFull Year Results
MyHealthChecked PLCHalf Year Results
Moonpig Group PLCTrading Statement
Naked Wines PLCFull Year Results
Northcoders Group PLCHalf Year Results
Ocado Group PLCTrading Statement
Serica Energy PLCHalf Year Results
SThree PLCTrading Statement
Surgical Innovations Group PLCHalf Year Results
Team17 Group PLCHalf Year Results
Trustpilot Group PLCHalf Year Results
Water Intelligence PLCHalf Year Results
Xaar PLCHalf Year Results
Wednesday 20 September 
Advanced Medical Solutions Group PLCHalf Year Results
ASA International Group PLCHalf Year Results
Destiny Pharma PLCHalf Year Results
Dunelm Group PLCTrading Statement
Epwin Group PLCHalf Year Results
Galliford Try Holdings PLCFull Year Results
GENinCode PLCHalf Year Results
HydrogenOne Capital Growth PLCHalf Year Results
Judges Scientific PLCHalf Year Results
LBG Media PLCHalf Year Results
M&G PLCHalf Year Results
Oxford Biomedica PLCHalf Year Results
PYX Resources LtdHalf Year Results
Round Hill Music Royalty Fund LtdHalf Year Results
Supermarket Income REIT PLCFull Year Results
Ten Entertainment Group PLCHalf Year Results
Warpaint London PLCHalf Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
31 Jul 2023 17:31

TRADING UPDATES: MGC Pharmaceuticals granted psilocybin import permit

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
25 Jul 2023 14:27

IN BRIEF: Destiny Pharma says former Chair Nigel Rudd return to role

Destiny Pharma PLC - Brighton, England-based clinical-stage biotechnology company focused on preventing life-threatening infections - Says Nigel Rudd will be returning as chair, effective immediately. He was chair of Destiny from 2010 to 2018, and led its flotation on the London AIM market.

Read more
19 Jul 2023 13:16

IN BRIEF: Destiny Pharma appoints Chris Tovey as CEO; Chair resigns

Destiny Pharma PLC - Brighton, England-based clinical-stage biotechnology company focused on preventing life-threatening infections - Appoints Chris Tovey as chief executive officer from September 1, taking over from Interim CEO Debra Barker who will return to position of non-executive director. The company announces departure of Chair Nick Rodgers, expects to announce new outside chair shortly.

Read more
6 Jul 2023 12:49

IN BRIEF: Destiny Pharma confirms phase 3 development for lead asset

Destiny Pharma PLC - Brighton, England-based clinical-stage biotechnology company focused on preventing life-threatening infections - Confirms proposed phase three development pathway and identifies new life cycle management targets for its XF-73 Nasal programme. Says antimicrobial properties of XF-73 Nasal give greater flexibility in the scheduling of surgeries. Adds there is potential to explore new life management indications, particularly in children.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.